The largest IPO in history trades Friday. Before you touch the buy button, here is what the prospectus and the deal mechanics actually say.
By Ruslan Averin.
This is Ruslan Averin's read of the SpaceX deal mechanics — twelve facts, no cheerleading.
1. Three businesses, one ticker. You are buying reusable launch, Starlink (10M+ subscribers), and the merged xAI division in a single share.
2. Starlink is the profit engine. It generated a $4.4 billion operating profit in 2025 on subscription revenue — the part of the company that already works like a business.
3. The AI division is the lottery ticket. Currently loss-making, with a claimed $26.5 trillion addressable market. Goldman projects its revenue could grow 100-fold by 2030.
4. The compute deals are real. The AI unit books $1.25 billion a month from Anthropic and $920 million a month from Google for computing capacity.
5. Musk keeps control. Super-voting shares give him over 85% of voting power pre-IPO and roughly 82% after. You are a passenger, not a co-pilot.
6. Demand is heavy. The book is at least twice oversubscribed — about $150 billion of demand against a $75 billion deal.
7. Retail gets 30%. Triple the usual allocation. That is a deliberate strategy, and it means the first weeks of trading will be retail-sentiment-driven.
8. Index inclusion is fast — mostly. SPCX can enter nearly every major US index within about three weeks of trading.
9. But not the S&P 500. That requires a year of trading history and profitability. The biggest passive bid arrives late.
10. The liquidity drain is real. Strategists warn retail could unload $50 billion of other stocks to fund SPCX purchases — pressure on the rest of your portfolio, not just a SpaceX story.
11. Lockups are staggered. Insiders can sell 20% of holdings after the first earnings report. Musk himself is locked up for a full year.
12. The valuation gap is enormous. The deal prices SpaceX at $1.77 trillion. Morningstar's independent estimate: $780 billion. The difference is faith, priced in cash.
The bottom line
A 3x-oversubscribed book, a 30% retail tranche, and a valuation more than double the most credible independent estimate — that is a recipe for a spectacular debut and a volatile first year. Patient capital lets the lockups and the index flows play out before deciding what SpaceX is actually worth.